[NH2:1][CH:2]([C:4]1[CH:5]=[C:6]([N:10]2[CH2:15][CH2:14][O:13][C@H:12]([CH2:16][OH:17])[CH2:11]2)[CH:7]=[CH:8][CH:9]=1)[CH3:3].[C:18](O)(=[O:27])[CH:19]=[CH:20][C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1.C(Cl)CCl.C(N(CC)CC)C>CN(C1C=CN=CC=1)C.ClCCl>[OH:17][CH2:16][CH:12]1[O:13][CH2:14][CH2:15][N:10]([C:6]2[CH:5]=[C:4]([C@@H:2]([NH:1][C:18](=[O:27])[CH:19]=[CH:20][C:21]3[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=3)[CH3:3])[CH:9]=[CH:8][CH:7]=2)[CH2:11]1Mixture of (S)-{4-[3-(1-amino-ethyl)-phenyl]-morpholin-2-yl}-methanol (27 mg, 0.09 mmol), cinnamic acid, Preparation 27 (12.8 mg, 0.09 mmol), EDC (34 mg, 0.18 mmol), DMAP (11 mg, 0.09 mmol), triethylamine (0.05 ml, 0.36 mmol) in dichloromethane (0.6 ml) was stirred at room temperature overnight. The reaction mixture was purified by filtering through 2 g silica-gel syringe with 60:40:1 acetone:hexanes:methanol. The filtrate was concentrated under vacuum to provide the title compound as a white solid.